Ultragenyx Pharmaceutical In
Top 10 Superinvestors by Shares Owned
This chart shows the top 10 superinvestors based on the number of shares they owned in 2024-Q3 and 2024-Q4. According to the most recent SEC 13F filing, 17 superinvestors own shares of Ultragenyx Pharmaceutical In (RARE), although recent data may remain incomplete due to pending filings.
Quarter-over-Quarter Change (%)
This chart highlights the quarter-over-quarter change (%) in the number of superinvestors holding Ultragenyx Pharmaceutical In (RARE), the total shares they held, and the total reported dollar value. It gives a clear view of whether there is ongoing momentum. The dotted lines at the top and bottom adjust longer bars to keep smaller data points visible for better comparison.
Superinvestors' Activity (%) Over the Last 4 Quarters
This chart shows superinvestors' activity with Ultragenyx Pharmaceutical In (RARE) over the last four quarters, highlighting the percentage of investors who added, increased, decreased, held, or exited their positions, revealing shifts in sentiment over time.
Superinvestors' Past Actions
This chart displays superinvestors' past actions with Ultragenyx Pharmaceutical In (RARE) over the last 10 years (40 quarters), helping to visualize the collective momentum and investment trends over time.
Superinvestors ownership
| Superinvestor | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
Rasmus Kroner@Nordea Investment Management Ab
| 0.01% | $1.658M 39,673 shares@ 41.8 avg price | Increased 8.92% |
Eric Duncan@Wealth Enhancement Advisory Services, Llc
| 0.01% | $1.225M 22,047 shares@ 55.56 avg price | Increased 1.36% |
Lorraine Wang@Gamma Investing Llc
| 0.01% | $17,838 424 shares@ 42.08 avg price | Increased 7.35% |
Daken Vanderburg@Massmutual Private Wealth & Trust, Fsb
| 0.01% | $7,194 171 shares@ 42.08 avg price | Increased 850% |
Brandon Yee@Versant Capital Management, Inc
| 0.01% | $6,689 159 shares@ 42.07 avg price | Increased 103.85% |